Canada Markets open in 2 hrs 2 mins

Khiron Life Sciences Corp. (KHRNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2278+0.0013 (+0.59%)
At close: 3:12PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.2265
Open0.2087
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2087 - 0.2296
52 Week Range0.2060 - 0.6170
Volume47,312
Avg. Volume372,973
Market Cap34.341M
Beta (5Y Monthly)2.01
PE Ratio (TTM)N/A
EPS (TTM)-0.1290
Earnings DateApr. 29, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    Khiron Receives Approval To Renew Its Normal Course Issuer Bid

    Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce that, further to its September 9, 2021 press release, the Company has received final approval from the TSX Venture Exchange (the "TSXV") to renew its normal course issuer bid to repurchase, for cancellation, up to 8,955,853 common shares of the Company ("Shares"), representing approximately

  • CNW Group

    Khiron Announces Intention to Renew its Normal Course Issuer Bid

    Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF) , (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announces today its intention to renew its prior normal course issuer bid through the facilities of the TSX Venture Exchange (the "TSXV") to repurchase, for cancellation, up to 8,955,893 common shares of the Company ("Shares"), representing approximately 5% of the Company's presently issued and outstan

  • CNW Group

    Khiron Registers its First Two Medical Cannabis Products in Peru, Available for Sale Nationwide

    Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, is pleased to announce it has received sanitary registration in Peru for Alixen™ 30 and Alixen™ 100, two CBD-rich products, which represent the Company's first two registered finished medical cannabis products. As registered medical products, Alixen™ 30 and Alixen™ 100 will be available for distrib